Correspondence 0001193125-25-022508 from Kezar Life Sciences, Inc. (KZR) (CIK 0001645666) (KZR)
Kezar Life Sciences, Inc. (KZR) (CIK 0001645666)
Date: Feb. 7, 2025 · CIK: 0001645666 · Accession: 0001193125-25-022508
AI Filing Summary & Sentiment
File numbers found in text: 333-284712
Letter
KEZAR LIFE SCIENCES, INC.
4000 Shoreline Court, Suite 300
South San Francisco, California 94080
(650) 822-5600
February 7, 2025
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Jessica Dickerson
RE: Kezar Life Sciences, Inc.
Registration Statement on Form S-3
File No. 333-284712
Acceleration Request
Requested Date: February 10, 2025
Requested Time: 4:00 p.m., Eastern time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Exchange Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-284712) (the “Registration Statement”) to become effective at 4:00 p.m. Eastern time on February 10, 2025, or as soon thereafter as is practicable.
Once the Registration Statement has been declared effective, please orally confirm that event with Jaime Chase of Cooley LLP, counsel to the registrant, at (202) 728-7096.
[Signature page follows]
Sincerely,
KEZAR LIFE SCIENCES, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP KEZAR LIFE SCIENCES, INC. 4000 Shoreline Court, Suite 300 South San Francisco, California 94080 (650) 822-5600 February 7, 2025 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Jessica Dickerson RE: Kezar Life Sciences, Inc. Registration Statement on Form S-3 File No. 333-284712 Acceleration Request Requested Date: February 10, 2025 Requested Time: 4:00 p.m., Eastern time Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Exchange Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-284712) (the “Registration Statement”) to become effective at 4:00 p.m. Eastern time on February 10, 2025, or as soon thereafter as is practicable. Once the Registration Statement has been declared effective, please orally confirm that event with Jaime Chase of Cooley LLP, counsel to the registrant, at (202) 728-7096. [Signature page follows] Sincerely, KEZAR LIFE SCIENCES, INC. By: /s/ Marc Belsky Marc Belsky Chief Financial Officer and Secretary cc: Laura Berezin, Cooley LLP Jaime Chase, Cooley LLP